Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,250.00
+190.00 (4.68%)
At close: Sep 11, 2026

Genesystem Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
1,010381.361,208897.033,653
Revenue Growth
-4.59%-68.42%34.64%-75.44%-
Gross Profit
-2,008-2,465-1,820-1,5861,167
Operating Income
-7,852-9,690-10,116-9,484-6,605
Net Income
-10,282-11,955-8,915-7,915-8,996
Earnings Per Share
-1418.71-1754.01-1302.00-1139.05-1303.50
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
4,8201,8747,69414,34826,489
Total Debt
3,8874,0454,1214,4884,095
Net Cash (Debt)
932.7-2,1723,5749,86022,394
Net Cash Growth
568.83%--63.75%-55.97%-
Net Cash Per Share
128.70-318.62521.911418.863244.73

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-8,284-6,883-7,337-7,812-6,417
Capital Expenditures
-521.75-219.66-258.73-362.85-238.43
Free Cash Flow
-8,806-7,103-7,595-8,174-6,655
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
-198.81%--150.69%-176.81%31.96%
Operating Margin
-777.39%-2541.03%-837.58%-1057.33%-180.80%
Pretax Margin
-1375.23%-4172.23%-801.44%-882.09%-193.26%
Profit Margin
-1017.98%-3134.97%-738.17%-882.41%-246.26%
FCF Margin
-871.87%-1862.60%-628.89%-911.27%-182.18%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Forward PE
-14.8514.8514.85-
PS Ratio
34.8773.3349.1572.6515.88